Shelton Emerging Markets Fund (EMSLX)

Fund Objective

Seeks to achieve long-term capital appreciation.

Strategy Benefits

  • “Controlled Growth” international strategy (“Diversified Emerging Markets” box in Morningstar).
  • Concentrated portfolio (30-50 stocks) with a high active share and relatively lower tracking error.
  • Investment in some of the best-managed companies around the world.
  • Access to fast-growing, emerging markets.

Strategy Considerations

  • All investments involve risk including the possible loss of principal. There can be no assurance the strategy will achieve its investment objective.
  • Foreign currency fluctuations can add volatility to foreign equity prices.

Overall Morningstar RatingTM

morning star rating 4 starsmorning star rating 4 starsmorning star rating 4 starsmorning star rating 4 stars EMSLX

EMSLX received an Overall Morningstar RatingTM of 4 stars among 711 Diversified Emerging Markets funds, based on risk-adjusted returns, as of 9/30/2024.* Important Information for Morningstar® Rating

Fund Information

Emerging Market Funds
 Download Fact Sheet: Shelton Emerging Markets Fund
Tickers: EMSQX, EMSLX
Benchmark: MSCI Emerging Markets		 Download Commentary

Literature and Fund Information

Invest Now

Fund Management

Derek Izuel
CIO and Portfolio Manager

Derek Izuel, CFA
Portfolio Manager

Justin Sheetz, CFA
Derek Izuel

CIO and Portfolio Manager

Derek Izuel, CFA

Derek joined Shelton Capital Management in January 2022 as Chief Investment Officer and Portfolio Manager of the International Fund and the Emerging Markets Fund. He has over 24 years of portfolio management experience at Invesco, HighMark Capital and Vitruvian Capital. Derek earned his MBA from the Ross School of Business at the University of Michigan and a B.S. in Computer Science from the University of California at Berkley.

Portfolio Manager

Justin Sheetz, CFA

Justin joined Shelton Capital Management in January 2022 as Portfolio Manager of the International Fund and the Emerging Markets Fund. His experience ranges from 12 years as an Investment Strategist at Blackrock/BGI’s Scientific Active Equity Group, 3 years as VP and Equity Analyst at HighMark Capital to 3 years as partner at Vitruvian Capital. Justin earned his MSc in Computational Finance and Risk Management from the University of Washington and a B.A. in International Studies from Colby College.

Important Information

An investment in the Fund involves risk, including loss of principal. Past performance does not guarantee future results. Fund information is not intended to represent future portfolio composition. Portfolio holdings are subject to change and should not be considered a recommendation to buy individual securities.

*The fund’s Morningstar three-, five-, ten-year ratings respectively, 4 stars, 4 stars, 4 stars among 711, 639, 426 funds.

There may be additional risks associated with international investing involving foreign, economic, political, monetary, and/or legal factors. International investing may not be for everyone. The information contained on this website is given on a general basis without obligation and on the understanding that any person acting upon or in reliance on it, does so entirely at his or her own risk. Any projections or other forward-looking statements regarding future events or performance of countries, markets or companies are not necessarily indicative of, and may differ from, actual events or results. This information is intended to highlight issues and not to be comprehensive or to provide advice.